Mechanistic modeling quantifies the influence of tumor growth kinetics on the response to anti-angiogenic treatment.
Tumors exploit angiogenesis, the formation of new blood vessels from pre-existing vasculature, in order to obtain nutrients required for continued growth and proliferation. Targeting factors that regulate angiogenesis, including the potent promoter vascular endothelial growth factor (VEGF), is there...
Main Authors: | Thomas D Gaddy, Qianhui Wu, Alyssa D Arnheim, Stacey D Finley |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-12-01
|
Series: | PLoS Computational Biology |
Online Access: | https://doi.org/10.1371/journal.pcbi.1005874 |
Similar Items
-
Mechanistic insights into the heterogeneous response to anti‐VEGF treatment in tumors
by: Ding Li, et al.
Published: (2021-06-01) -
Exploring the Extracellular Regulation of the Tumor Angiogenic Interaction Network Using a Systems Biology Model
by: Ding Li, et al.
Published: (2019-07-01) -
ERK and Akt exhibit distinct signaling responses following stimulation by pro-angiogenic factors
by: Min Song, et al.
Published: (2020-07-01) -
Limitations of Anti-Angiogenic Treatment of Tumors
by: Domenico Ribatti, et al.
Published: (2019-07-01) -
Trends and Challenges in Tumor Anti-Angiogenic Therapies
by: József Jászai, et al.
Published: (2019-09-01)